Home/Filings/4/0001753926-22-001648
4//SEC Filing

Chancellor Michael B 4

Accession 0001753926-22-001648

CIK 0001347242other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 7:06 PM ET

Size

4.9 KB

Accession

0001753926-22-001648

Insider Transaction Report

Form 4
Period: 2022-12-22
Chancellor Michael B
DirectorChief Medical Officer10% Owner
Transactions
  • Other

    Common Stock

    2022-12-22$5.75/sh+22,950$131,963732,730 total
Footnotes (1)
  • [F1]The Reporting Person received 22,950 shares of common stock, par value $0.0001 per share, upon the cancellation of promissory notes of the Issuer held by the Reporting Person.

Documents

1 file

Issuer

LIPELLA PHARMACEUTICALS INC

CIK 0001347242

Entity typeother

Related Parties

1
  • filerCIK 0001959360

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:06 PM ET
Size
4.9 KB